Uniqure N V (QURE)

Mar 31, 2025

Sanofi Set To Shake Up Crowded Hemophilia Space After Qfitlia Approval - insights.citeline.com

Mar 31, 2025

Mar 26, 2025

Learn to Evaluate (QURE) using the Charts - Stock Traders Daily

Mar 26, 2025

Mar 25, 2025

Stock Watch: Are Gene Therapy Prices Too High For Success? - insights.citeline.com

Mar 25, 2025

Mar 16, 2025

(QURE) Trading Report - Stock Traders Daily

Mar 16, 2025

Mar 13, 2025

uniQure (NASDAQ:QURE) Stock Rating Upgraded by StockNews.com - Defense World

Mar 13, 2025

Mar 09, 2025

Oppenheimer & Co. Inc. Buys New Stake in uniQure (NASDAQ:QURE) - Defense World

Mar 09, 2025

Mar 08, 2025

FY2025 Earnings Estimate for uniQure Issued By HC Wainwright - Defense World

Mar 08, 2025

Mar 06, 2025

uniQure (NASDAQ:QURE) Earns Buy Rating from HC Wainwright - Defense World

Mar 06, 2025

Mar 06, 2025

uniQure CFO Christian Klemt sells $107,407 in shares By Investing.com - Investing.com Australia

Mar 06, 2025

Mar 05, 2025

uniQure Reports 2024 Financial Results and Progress - TipRanks

Mar 05, 2025

Mar 05, 2025

uniQure’s chief medical officer sells shares worth $13,891 - Investing.com India

Mar 05, 2025

Mar 05, 2025

uniQure CFO Christian Klemt sells $107,407 in shares - Investing.com India

Mar 05, 2025

Mar 05, 2025

uniQure’s chief medical officer sells shares worth $13,891 By Investing.com - Investing.com South Africa

Mar 05, 2025

Mar 05, 2025

uniQure CEO Matthew Kapusta sells shares worth $291,628 By Investing.com - Investing.com South Africa

Mar 05, 2025

Mar 05, 2025

uniQure chief legal officer sells shares for $72,812 By Investing.com - Investing.com South Africa

Mar 05, 2025

Mar 05, 2025

uniQure CEO Matthew Kapusta sells shares worth $291,628 - Investing.com

Mar 05, 2025

Mar 05, 2025

uniQure chief legal officer sells shares for $72,812 - Investing.com

Mar 05, 2025

Mar 04, 2025

uniQure (NASDAQ:QURE) Stock Price Down 7.3% Following Analyst Downgrade - Defense World

Mar 04, 2025

Mar 03, 2025

Wells Fargo & Company Cuts uniQure (NASDAQ:QURE) Price Target to $30.00 - Defense World

Mar 03, 2025

Mar 03, 2025

What is William Blair’s Forecast for uniQure Q1 Earnings? - Defense World

Mar 03, 2025

Mar 02, 2025

Don't Ignore The Insider Selling In uniQure - Simply Wall St

Mar 02, 2025

Mar 02, 2025

Q1 Earnings Estimate for uniQure Issued By William Blair - Defense World

Mar 02, 2025

Mar 01, 2025

uniQure Full Year 2024 Earnings: Misses Expectations - Yahoo Finance

Mar 01, 2025

Feb 28, 2025

Insider Selling: uniQure (NASDAQ:QURE) CEO Sells 26,727 Shares of Stock - MarketBeat

Feb 28, 2025

Feb 28, 2025

uniQure (NASDAQ:QURE) CEO Matthew C. Kapusta Sells 6,717 Shares - MarketBeat

Feb 28, 2025

Feb 28, 2025

uniQure (NASDAQ:QURE) CFO Christian Klemt Sells 14,341 Shares - MarketBeat

Feb 28, 2025

Feb 28, 2025

uniQure (NASDAQ:QURE) CFO Christian Klemt Sells 2,916 Shares - MarketBeat

Feb 28, 2025

Feb 28, 2025

uniQure (NASDAQ:QURE) Releases Quarterly Earnings Results, Misses Expectations By $0.90 EPS - MarketBeat

Feb 28, 2025

Feb 28, 2025

uniQure (NASDAQ:QURE) Shares Down 9.5%Should You Sell? - MarketBeat

Feb 28, 2025

Feb 28, 2025

uniQure (NASDAQ:QURE) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Feb 28, 2025

Feb 28, 2025

uniQure (NASDAQ:QURE) Given Average Rating of “Buy” by Brokerages - Defense World

Feb 28, 2025

Feb 28, 2025

Uniqure NV earnings missed by $0.82, revenue fell short of estimates - Investing.com Australia

Feb 28, 2025

Feb 27, 2025

uniQure CEO Matthew Kapusta sells over $360,000 in stock By Investing.com - Investing.com South Africa

Feb 27, 2025

Feb 27, 2025

uniQure CEO Matthew Kapusta sells over $360,000 in stock - Investing.com India

Feb 27, 2025

Feb 27, 2025

uniQure CFO Christian Klemt sells shares worth over $186,000 By Investing.com - Investing.com South Africa

Feb 27, 2025

Feb 27, 2025

uniQure CFO Christian Klemt sells shares worth over $186,000 - Investing.com

Feb 27, 2025

Feb 27, 2025

Uniqure NV reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 27, 2025

Feb 27, 2025

uniQure N.V. SEC 10-K Report - TradingView

Feb 27, 2025

Feb 27, 2025

UniQure (QURE) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance

Feb 27, 2025

Feb 27, 2025

uniQure Reports 2024 Financial Results and Company Progress - TradingView

Feb 27, 2025

Feb 27, 2025

uniQure N.V. Reports Progress with AMT-130 for Huntington’s Disease and Updates on Clinical Trials Across its Gene Therapy Pipeline - Nasdaq

Feb 27, 2025

Feb 27, 2025

uniQure Announces 2024 Financial Results and Highlights Recent Company Progress - GlobeNewswire

Feb 27, 2025

Feb 26, 2025

uniQure N.V.: A Potential Huntington's Play - Seeking Alpha

Feb 26, 2025

Feb 25, 2025

uniQure (QURE) Expected to Announce Earnings on Wednesday - Defense World

Feb 25, 2025

Feb 23, 2025

(QURE) Technical Data - Stock Traders Daily

Feb 23, 2025

Feb 21, 2025

Huntington's Disease Market Growth to Accelerate in Forecast - openPR

Feb 21, 2025

Feb 20, 2025

Pfizer nixes Roche-partnered hemophilia drug (PFE:NYSE) - Seeking Alpha

Feb 20, 2025

Feb 20, 2025

uniQure: Gene Therapy Specialist Looks Set For Upside As Huntington's Approval Beckons - Seeking Alpha

Feb 20, 2025

Feb 20, 2025

uniQure N.V. (NASDAQ:QURE) is a favorite amongst institutional investors who own 66% - Yahoo Finance

Feb 20, 2025

Feb 19, 2025

24,749 Shares in uniQure (NASDAQ:QURE) Acquired by Palumbo Wealth Management LLC - MarketBeat

Feb 19, 2025

Feb 19, 2025

uniQure (NASDAQ:QURE) Stock Passes Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat

Feb 19, 2025